Lingling Li

6PUBLICATIONS
30CO-AUTHORS
Cancer cell biologyWastewater treatment processesPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2026
A Look Behind the Paper: Glypican-3-targeted US Molecular Imaging of Hepatocellular Carcinoma.

Xiaoxin Liang, Lingling Li, Yuanyuan Wang

|Mar 06, 2026
US Molecular Imaging of Glypican-3 Expression in Hepatocellular Carcinoma Using Targeted Biosynthetic Gas Vesicles.

Xiaoxin Liang, Lingling Li, Yuanyuan Wang

|Mar 03, 2026
Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018.

Yu Li, Shilin Lu, Siyue Mao

|Feb 27, 2025
Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients.

Yu Li, Sheng Li, Qing Li

|Sep 10, 2024
Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer.

Jing Han, Min Lin, Qingguang Lin

|Aug 29, 2023
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.

Lingling Li, Xuebin Zou, Wei Zheng

Pageof 1

Frequent Collaborators

6 joint publications

Jianhua Zhou

3 joint publications

Shilin Lu

3 joint publications

Yu Li

3 joint publications

Jing Han